Insider screener

Period: 12 months Plan: Scheduled (10b5-1) × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23,452 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23,452 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23,452 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23,452 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23,452 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23,452 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23,452 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
17 Feb 2026
Ribeiro Ramiro Chief Medical Officer
Sold on a plan
$36.56K 2,437 at 15.00
100%
Sold half or more
17 Feb 2026
Shaw Theresa A SVP and CATO
Sold on a plan
$36.36K 325 at 111.89
0.9%
Planned (10b5-1)
17 Feb 2026
Heyman Richard A. Director · indirect
Sold on a plan
$32.20K 1,230 at 26.18
5.2%
Planned (10b5-1)
17 Feb 2026
Lee Timothy Edward Chief Commercial Officer
Sold on a plan
$30.27K 19,663 at 1.54
12.4%
Planned (10b5-1)
17 Feb 2026
Duke William E. Chief Financial Officer
Sold on a plan
$30.27K 19,663 at 1.54
13.3%
Planned (10b5-1)
17 Feb 2026
Green Julie Chief Human Resources Officer
Sold on a plan
$30.27K 19,663 at 1.54
13.3%
Planned (10b5-1)
17 Feb 2026
Yi Steven See Remarks
Sold on a plan
$28.64K 4,000 at 7.16
0.1%
Planned (10b5-1)
17 Feb 2026
Allen Robert D. III Chief Scientific Officer
Sold on a plan
$28.00K 18,189 at 1.54
12.0%
Planned (10b5-1)
17 Feb 2026
Parvizi Josef Director · indirect
Sold on a plan
$26.00K 1,300 at 20.00
0.2%
Planned (10b5-1)
17 Feb 2026
De Lorenzo Daniel VP, Controller & CAO
Sold on a plan
$25.66K 252 at 101.84
100%
Sold half or more
17 Feb 2026
Domino Michael Wayne Jr. President, DTR Division
Sold on a plan 2×
$24.75K 6,249 at 3.96
0.4%
Planned (10b5-1)
17 Feb 2026
MALCOLM JAN Director
Sold on a plan
$23.73K 50 at 474.68
18.5%
Planned (10b5-1)
17 Feb 2026
Sumner Crystal See Remarks
Sold on a plan
$20.21K 5,056 at 4.00
1.6%
Planned (10b5-1)
17 Feb 2026
Sold on a plan
$19.96K 750 at 26.61
0.5%
Planned (10b5-1)
17 Feb 2026
Olsson Staffan EVP, Operations
Sold on a plan
$14.86K 119 at 124.89
5.3%
Planned (10b5-1)
17 Feb 2026
Blow Marla J Director
Sold on a plan 2×
$13.41K 300 at 44.68
3.3%
Planned (10b5-1)
17 Feb 2026
Denny Laurence Chief Legal Officer
Sold on a plan
$12.73K 5,000 at 2.55
1.3%
Planned (10b5-1)
17 Feb 2026
Rodman David Malcom Chief Medical Officer
Sold on a plan
$11.51K 417 at 27.59
0.9%
Planned (10b5-1)
17 Feb 2026
Cummings Martha Director
Sold on a plan
$11.41K 2,853 at 4.00
6.8%
Planned (10b5-1)
17 Feb 2026
Kerdman Alina SVP, Controller & CAO
Sold on a plan
$10.68K 160 at 66.75
20.3%
Planned (10b5-1)
17 Feb 2026
Sadri Ali Chief Technology Officer
Sold on a plan
$5.28K 1,000 at 5.28
0.8%
Planned (10b5-1)
17 Feb 2026
Milligan Michael Lee See Remarks
Sold on a plan
$5.12K 1,436 at 3.57
6.4%
Planned (10b5-1)
17 Feb 2026
O'Dowd William IV Chief Executive Officer
Bought on a plan
$4.85K 3,300 at 1.47
0.8%
Bought on a plan
15 Feb 2026
Francis Richard D President and CEO
Sold on a plan 2×
$15.32M 447,778 at 34.22
62.2%
Sold half or more
15 Feb 2026
Olivan Javier Chief Operating Officer
Sold on a plan
$1.57M 2,461 at 639.77
16.9%
Planned (10b5-1)
15 Feb 2026
Shaff Eric D. Director
Sold on a plan
$2.19K 259 at 8.47
2.2%
Planned (10b5-1)
15 Feb 2026
Henn Matthew R See Remarks
Sold on a plan
$753.83 89 at 8.47
1.1%
Planned (10b5-1)
15 Feb 2026
DesRosier Thomas See Remarks
Sold on a plan
$660.66 78 at 8.47
1.0%
Planned (10b5-1)
15 Feb 2026
Young Teresa L. See Remarks
Sold on a plan
$635.25 75 at 8.47
0.9%
Planned (10b5-1)
13 Feb 2026
Kempczinski Christopher J Chairman and CEO
Sold on a plan
$8.76M 26,276 at 333.54
53.4%
Sold half or more
13 Feb 2026
Reynal Vicente See Remarks
Sold on a plan
$5.61M 55,870 at 100.39
19.6%
Planned (10b5-1)
13 Feb 2026
Doherty Catherine T. EVP, Regional Businesses
Sold on a plan 5×
$5.39M 26,165 at 206.15
27.8%
Planned (10b5-1)
13 Feb 2026
Venker Eric President & Immunovant CEO
Sold on a plan
$5.30M 200,000 at 26.49
10.8%
Planned (10b5-1)
13 Feb 2026
Kroeger Shadrak W Pres., Industrial Solutions
Sold on a plan 11×
$3.73M 15,965 at 233.75
38.1%
Planned (10b5-1)
13 Feb 2026
Bergman Artur Chief Technology Officer · indirect
Sold on a plan 2×
$3.70M 200,847 at 18.42
8.0%
Planned (10b5-1)
13 Feb 2026
Sold on a plan 4×
$3.55M 10,000 at 355.18
1.0%
Planned (10b5-1)
13 Feb 2026
Mat Ishbia President and CEO · indirect
Sold on a plan
$3.13M 632,874 at 4.94
35.3%
Planned (10b5-1)
13 Feb 2026
Robinson Jill L. EVP, CFO & Treasurer
Sold on a plan
$2.52M 60,000 at 42.00
43.0%
Planned (10b5-1)
13 Feb 2026
Huffman Steve Ladd CEO & President · indirect
Sold on a plan 6×
$2.50M 18,000 at 138.81
3.9%
Planned (10b5-1)
13 Feb 2026
Landman Yoav CHIEF TECHNOLOGY OFFICER
Sold on a plan
$1.68M 30,000 at 55.86
0.5%
Planned (10b5-1)
13 Feb 2026
Robbins Charles Chair and CEO
Sold on a plan 4×
$1.49M 19,545 at 76.00
2.8%
Planned (10b5-1)
13 Feb 2026
Bought on a plan 3×
$1.40M 20,000 at 69.88
0.0%
Bought on a plan
13 Feb 2026
Swayze Eric EVP Research
Sold on a plan 2×
$1.28M 15,642 at 81.76
32.8%
Planned (10b5-1)
13 Feb 2026
Bohley G Frederick Allison COO,Pres.&BU Leader AT
Sold on a plan 3×
$1.20M 10,348 at 116.40
9.5%
Planned (10b5-1)
13 Feb 2026
Mansueto Joseph D Executive Chairman
Sold on a plan 6×
$1.13M 7,250 at 156.21
0.1%
Planned (10b5-1)
13 Feb 2026
Shah Shardul Director · indirect
Sold on a plan 7×
$998.89K 7,916 at 126.19
2.3%
Planned (10b5-1)
13 Feb 2026
Patel Jeetendra I President and CPO
Sold on a plan 4×
$854.85K 11,248 at 76.00
4.1%
Planned (10b5-1)
13 Feb 2026
Williams Toby J. President and CEO
Sold on a plan 2×
$837.19K 8,000 at 104.65
3.6%
Planned (10b5-1)
13 Feb 2026
HAYNE RICHARD A CEO & Chairman of the Board
Sold on a plan
$752.12K 10,667 at 70.51
0.1%
Planned (10b5-1)
13 Feb 2026
Tatsis Ourania EVP, Chief Reg. & Quality Off.
Sold on a plan
$749.99K 1,500 at 499.99
3.1%
Planned (10b5-1)
Showing 17,051–17,100 of 23,452. ← Newer Page 342 of 470 Older →